↓ Skip to main content

Is RANKL inhibition both anti-resorptive and anabolic in rheumatoid arthritis?

Overview of attention for article published in Arthritis Research & Therapy, November 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
21 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Is RANKL inhibition both anti-resorptive and anabolic in rheumatoid arthritis?
Published in
Arthritis Research & Therapy, November 2015
DOI 10.1186/s13075-015-0861-5
Pubmed ID
Authors

Natalie A. Sims, Evange Romas

Abstract

A small peptide, OP3-4, blocks receptor activator of NF-κB from binding to its ligand, receptor activator of NF-κB ligand (RANKL), and was reported recently to inhibit bone resorption, promote bone formation and protect cartilage in a preclinical rheumatoid arthritis model. The latter effects may result from inhibition of RANKL reverse signalling in osteoblasts and chondrocytes. Whether other RANKL inhibitors, such as denosumab, share this action is not known, but OP3-4 at least has potential to provide anabolic treatment for both systemic and focal bone loss in inflammatory arthritis.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 5%
China 1 5%
Unknown 19 90%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 3 14%
Professor > Associate Professor 3 14%
Student > Master 3 14%
Student > Bachelor 2 10%
Researcher 2 10%
Other 3 14%
Unknown 5 24%
Readers by discipline Count As %
Medicine and Dentistry 7 33%
Pharmacology, Toxicology and Pharmaceutical Science 3 14%
Veterinary Science and Veterinary Medicine 1 5%
Psychology 1 5%
Biochemistry, Genetics and Molecular Biology 1 5%
Other 0 0%
Unknown 8 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 November 2015.
All research outputs
#4,836,328
of 25,374,917 outputs
Outputs from Arthritis Research & Therapy
#1,028
of 3,381 outputs
Outputs of similar age
#72,008
of 392,665 outputs
Outputs of similar age from Arthritis Research & Therapy
#65
of 101 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,381 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 392,665 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 101 others from the same source and published within six weeks on either side of this one. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.